IDLB Invesco FTSE International Low Beta Equal Weight ETF
Quote as of Mar 30, 2023 17:42 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Previous Close | 23.99 | Day Range | 23.99 – 24.08 |
| 52-Week Range | 23.25 – 25.73 | Volume | 566 |
| Avg Volume | 94 | AUM | $4.8M (Aug 27, 2026) |
| Expense Ratio | 0.45% | Yield (TTM) | — |
| NAV | 24.15 | Premium/Discount | -0.29% indicative |
| Inception | Nov 05, 2015 | Holdings | 17 |
| Issuer | Invesco | Exchange | NASDAQ |
| Category | Healthcare | Index Tracked | Not stated in source data |
| CUSIP | 46138E768 | ISIN | US46138E7682 |
| Management | Not stated in source data | ||
About this ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, the index provider compiles, maintains and calculates the underlying index, which is designed to provide exposure to constituents of the FTSE Developed ex US Index that exhibit low beta characteristics.
Description from the fund data provider · profile as of Aug 27, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | -2.19% | +0.58% | +12.42% | 0.00% | -10.85% | +3.14% | -4.33% | — | -0.54% |
| Total return | -1.79% | +1.01% | +13.32% | +0.42% | -8.58% | +5.67% | -1.63% | — | +2.07% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Apr 06, 2023. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.45% | Annual cost of a $10,000 investment | $45.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of May 05, 2023 — portfolio reporting date from the data provider; holdings are not live positions. 17 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | Cash/Receivables/Payables | -CASH- | 99.84% | 4.85M | $4.8M |
| 2 | Cash/Receivables/Payables | — | 0.12% | 5.54K | $6.1K |
| 3 | Cash/Receivables/Payables | -SOUTHKORE | 0.03% | 1.96M | $1.5K |
| 4 | Celltrion Healthcare Co Ltd | — | 0.00% | 4 | $188.32 |
| 5 | Cash/Receivables/Payables | -AUSTRALIA | 0.00% | 151 | $101.24 |
| 6 | Cash/Receivables/Payables | — | 0.00% | 67 | $82.95 |
| 7 | Cash/Receivables/Payables | -SWEDKRONA | 0.00% | 0 | $0.02 |
| 8 | Cash/Receivables/Payables | -DENMARKKR | 0.00% | 0 | -$0.03 |
| 9 | Cash/Receivables/Payables | -NEWZEALND | 0.00% | 0 | -$0.17 |
| 10 | Cash/Receivables/Payables | -SWISSFRAN | 0.00% | 0 | -$0.30 |
| 11 | Cash/Receivables/Payables | -HONGKONG | 0.00% | -6 | -$0.75 |
| 12 | Cash/Receivables/Payables | -ISRAELSHE | 0.00% | -3 | -$0.85 |
| 13 | Cash/Receivables/Payables | — | 0.00% | -8 | -$1.85 |
| 14 | Cash/Receivables/Payables | — | 0.00% | -5 | -$3.74 |
| 15 | Cash/Receivables/Payables | -SINGAPORE | 0.00% | -47 | -$35.53 |
| 16 | Cash/Receivables/Payables | -NORWAYKRN | 0.00% | -695 | -$66.59 |
| 17 | Cash/Receivables/Payables | — | 0.00% | -11.00K | -$84.03 |
Click a ticker to see every ETF that owns it.
Sector Exposure
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | — | Paid (last 12 months) | — |
| Frequency | Quarterly | SEC yield | Not provided by our data source — see the issuer page |
| Last ex-date | Mar 28, 2023 | Last payment | $0.1000 (Apr 06, 2023) |
| Growth 1Y | — | Growth 3Y / 5Y (ann.) | — / — |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Mar 28, 2023 | Mar 29, 2023 | Apr 06, 2023 | $0.1000 |
| Dec 19, 2022 | Dec 20, 2022 | Dec 23, 2022 | $0.0870 |
| Sep 19, 2022 | Sep 20, 2022 | Sep 23, 2022 | $0.1940 |
| Jun 21, 2022 | Jun 22, 2022 | Jun 30, 2022 | $0.2090 |
| Mar 21, 2022 | Mar 22, 2022 | Mar 31, 2022 | $0.1730 |
| Dec 20, 2021 | Dec 21, 2021 | Dec 31, 2021 | $0.5400 |
| Sep 20, 2021 | Sep 21, 2021 | Sep 30, 2021 | $0.2050 |
| Jun 21, 2021 | Jun 22, 2021 | Jun 30, 2021 | $0.1460 |
| Mar 22, 2021 | Mar 23, 2021 | Mar 31, 2021 | $0.1500 |
| Dec 21, 2020 | Dec 22, 2020 | Dec 31, 2020 | $0.1540 |
| Sep 21, 2020 | Sep 22, 2020 | Sep 30, 2020 | $0.0170 |
| Jun 22, 2020 | Jun 23, 2020 | Jun 30, 2020 | $0.0260 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
Liquidity
| Volume today | 566 | Average volume | 94 |
| AUM | $4.8M | Premium/Discount | -0.29% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV — an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source — review them before investing.
Latest News for IDLB
No articles mention this fund directly in the last 7 days — showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.